首页> 美国政府科技报告 >Exploiting bcl-2 Overexpression in the Chemotherapy of Breast Cancer
【24h】

Exploiting bcl-2 Overexpression in the Chemotherapy of Breast Cancer

机译:利用bcl-2过表达在乳腺癌化疗中的应用

获取原文

摘要

Previous studies have demonstrated that exposure of estrogen- responsive breast cancer cells in culture to estrogen leads to overexpression of bcl-2. Contrary to the case for apoptosis induced by conventional anticancer drugs, bcl-2 overexpression potentiates apoptosis induction by neocarzinostatin in neural crest tumor cells. We therefore examined the effects of neocarzinostatin on bcl-2- overexpressing breast cancer cells in culture. Unlike the case for neural crest tumor cells, overexpression of bcl-2 in MCF-7 cells did not afford potentiation of apoptosis induction by the reduction-dependent enediyne neocarzinostatin. Instead, MCF-7 cells were protected from apoptosis induced by neocarzinostatin. Two critical mechanistic differences have been discovered to relate to this finding. While bcl-2 overexpression in neural crest tumor cells leads to alteration of glutathione handling in the direction of greater reducing potential, bcl-2 overexpression in MCF-7 cells does not alter cellular redox potential or glutathione handling. Furthermore, neocarzinostatin treatment of neural crest tumor cells results in conversion of Bcl-2 protein to its pro-apoptotic cleavage products. This enzymatic cleavage is induced by caspase 3, an enzyme that is not expressed in MCF-7 cells. Predictably, only apoptosis induced by neocarzinostatin in neural crest tumor cells is inhibited by an inhibitor of caspase 3 activity.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号